Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MAI.2003.24PMID 12532086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects

  2002cited by this paper
• Clinical significance of bronchoalveolar eosinophils in childhood asthma.

  2002cited by this paper
• Leptin-Deficient Mice Exhibit Impaired Host Defense in Gram-Negative Pneumonia1

  2002cited by this paper
• FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr.

  2001cited by this paper
• A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

  2001cited by this paper
• Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

  2001cited by this paper
• The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control.

  2001cited by this paper
• Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone.

  2001cited by this paper
• Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma.

  2001cited by this paper
• Exhaled markers of pulmonary disease.

  2001cited by this paper
• Leukotriene modifiers in pediatric asthma management.

  2001cited by this paper
• Induced sputum--a tool with great potential but not without problems.

  2000cited by this paper
• Increased nitric oxide production in the respiratory tract in asymptomatic pacific islanders: an association with skin prick reactivity to house dust mite.

  2000cited by this paper
• 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States.

  2000cited by this paper
• Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels.

  2000cited by this paper
• Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients

  2000cited by this paper
• Antileukotriene therapy. Future directions.

  2000cited by this paper
• Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.

  2000cited by this paper
• Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

  2000cited by this paper
• Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness.

  2000cited by this paper
• Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics.

  2000cited by this paper
• Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness.

  2000cited by this paper
• Update on sputum methodology.

  2000cited by this paper
• Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey.

  2000cited by this paper
• Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.

  2000cited by this paper
• Effect of pranlukast on bronchial inflammation in patients with asthma

  2000cited by this paper
• Exhaled nitric oxide in patients with asthma: association with NOS1 genotype.

  2000cited by this paper
• Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.

  2000cited by this paper
• Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.

  2000cited by this paper
• A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma.

  2000cited by this paper
• Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

  1999cited by this paper
• The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthma

  1999cited by this paper
• Induced sputum eicosanoid concentrations in asthma.

  1999cited by this paper
• Non-eosinophilic corticosteroid unresponsive asthma.

  1999cited by this paper
• Contribution of Nitric Oxide Synthases 1, 2, and 3 to Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma

  1999cited by this paper
• Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia.

  1999cited by this paper
• E V ect of oral L -arginine on airway hyperresponsiveness to histamine in asthma

  1999cited by this paper
• Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.

  1999cited by this paper
• NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.

  1999cited by this paper
• Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis.

  1999cited by this paper
• Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma.

  1999cited by this paper
• Prednisone-dependent asthma: inflammatory indices in induced sputum.

  1999cited by this paper
• Childhood asthma: exhaled nitric oxide in relation to clinical symptoms.

  1999cited by this paper
• Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.

  1999cited by this paper
• Effects of ONO‐1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma

  1999cited by this paper
• Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma.

  1999cited by this paper
• Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children.

  1999cited by this paper
• Exhaled nitric oxide before and after montelukast sodium therapy in school‐age children with chronic asthma: A preliminary study

  1999cited by this paper
• Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast.

  1999cited by this paper
• Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway.

  1999cited by this paper
• Treatment of asthma with drugs modifying the leukotriene pathway.

  1999cited by this paper
• Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

  1998cited by this paper
• Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid

  1998cited by this paper
• Relationship between airway obstruction and respiratory symptoms in adult asthmatics.

  1998cited by this paper
• Potential masking effects of salmeterol on airway inflammation in asthma.

  1998cited by this paper
• Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

  1998cited by this paper
• Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

  1998cited by this paper
• Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared.

  1998cited by this paper
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial

  1998cited by this paper
• Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactions

  1998cited by this paper
• Use of induced sputum to examine airway inflammation in childhood asthma.

  1998cited by this paper
• Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma.

  1998cited by this paper
• Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids

  1998cited by this paper
• Relationship between exhaled nitric oxide and childhood asthma.

  1998cited by this paper
• Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.

  1998cited by this paper
• Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

  1998cited by this paper
• Leukotriene Receptors: Incompletely Defined Targets for Treatment of Asthma and Inflammation

  1998cited by this paper
• Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.

  1997cited by this paper
• Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma.

  1997cited by this paper
• Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.

  1997cited by this paper
• Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood.

  1997cited by this paper
• The use of induced sputum to investigate airway inflammation.

  1997cited by this paper
• Corticosteroids decrease exhaled nitric oxide in children with acute asthma.

  1997cited by this paper
• No .NO from NO synthase.

  1996cited by this paper
• Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.

  1996cited by this paper
• Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.

  1996cited by this paper
• Urinary leukotriene E4 in the assessment of nocturnal asthma.

  1996cited by this paper
• Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.

  1995cited by this paper
• Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.

  1995cited by this paper
• Exhaled nitric oxide is increased in asthma.

  1995cited by this paper
• Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.

  1995cited by this paper
• Exacerbations of asthma without sputum eosinophilia.

  1995cited by this paper
• Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide.

  1995cited by this paper
• High nitric oxide production in human paranasal sinuses

  1995cited by this paper
• Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid

  1995cited by this paper
• Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro

  1994cited by this paper
• Expression of inducible nitric oxide in human lung epithelial cells.

  1994cited by this paper
• Regulation of biosynthesis of nitric oxide.

  1994cited by this paper
• Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium.

  1994cited by this paper
• Effect of oral prednisone on airway inflammatory mediators in atopic asthma.

  1994cited by this paper
• Increased amount of nitric oxide in exhaled air of asthmatics.

  1993cited by this paper
• Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.

  1993cited by this paper
• Leukotriene E4 and granulocytic infiltration into asthmatic airways.

  1993cited by this paper
• Induction of nitric oxide synthase in asthma.

  1993cited by this paper
• Endogenous nitric oxide in single exhalations and the change during exercise.

  1993cited by this paper
• Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.

  1992cited by this paper
• A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid

  1992cited by this paper
• Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses.

  1992cited by this paper
• Use of induced sputum cell counts to investigate airway inflammation in asthma.

  1992cited by this paper
• The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma.

  1991cited by this paper

• Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes

  2018cites this paper
• Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases

  2017cites this paper
• Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.

  2016cites this paper
• A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood.

  2013cites this paper
• Role of antileukotrienes in acute asthma exacerbations Drugs

  2012cites this paper
• Antileukotrienes as Adjunctive Therapy in Acute Asthma

  2012cites this paper
• Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

  2011cites this paper
• What’s new in asthma pathophysiology and immunopathology?

  2010cites this paper
• Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists.

  2010cites this paper
• European Annals of Allergy and Clinical Immunology

  2010cites this paper
• Prospectivestudyofsensitizationandfoodallergyto flaxseedin1,317subjects

  2010cites this paper
• Levels of cysteinyl‐leukotrienes in exhaled breath condensate are not due to saliva contamination

  2010cites this paper
• What's new in asthma pathophysiology and

  2010cites this paper
• The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma.

  2010cites this paper
• Pitrakinra for asthma

  2010cites this paper
• Influência do montelucaste sobre o estado de ativação dos eosinófilos e função dos fagócitos em crianças asmáticas

  2010cites this paper
• Antileukotrienes in Asthma and Rhinitis

  2009cites this paper
• Exhaled leukotrienes and bronchial responsiveness to methacholine in patients with seasonal allergic rhinitis.

  2009cites this paper
• Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis

  2009cites this paper
• Patient-Centered Care for Childhood Asthma

  2009cites this paper
• Pretreatment with Albuterol versus Montelukast for Exercise‐Induced Bronchospasm in Children

  2008cites this paper
• The Role of 5-Lipoxygenase and Leukotrienes in Shock and Ischemia-Reperfusion Injury

  2007cites this paper
• Cysteinyl-Leukotriene Receptors and Cellular Signals

  2007cites this paper
• Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.

  2007cites this paper
• Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends

  2007cites this paper
• A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate

  2007cites this paper
• The Basic Science of Wound Healing

  2006cites this paper
• Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention.

  2006cites this paper
• The role of leukotrienes in airway inflammation.

  2006cites this paper
• LIPID MEDIATORS | Leukotrienes

  2006cites this paper
• Treating asthma: is there a place for leukotriene receptor antagonists?

  2005cites this paper
• Molecular mechanisms in allergy and clinical immunology

  2005cites this paper
• Antileucotrienos, revisión de la literatura

  2005cites this paper
• Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.

  2004cites this paper
• Molecular and functional aspects of human cysteinyl leukotriene receptors.

  2004cites this paper
• Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.

  2004cites this paper